Bioengineers/NNS/O set/VBD/O out/RP/O to/TO/O duplicate/VB/O that/DT/O feat/NN/O --/:/O scientifically/RB/O and/CC/O commercially/RB/O --/:/O with/IN/O new/JJ/O life/NN/O forms/NNS/O ././O
Twenty/CD/O years/NNS/O later/RB/O ,/,/O two/CD/O California/NNP/B-GPE academics/NNS/O ,/,/O Stanley/NNP/B-PERSON Cohen/NNP/I-PERSON and/CC/O Herbert/NNP/B-PERSON Boyer/NNP/I-PERSON ,/,/O made/VBD/O ``/``/O recombinant/JJ/O ''/''/O DNA/NN/O ,/,/O transplanting/VBG/O a/DT/O toad/NN/O 's/POS/O gene/NN/O into/IN/O bacteria/NNS/O ,/,/O which/WDT/O then/RB/O reproduced/VBD/O toad/NN/O genes/NNS/O ././O
Genentech/NNP/B-ORG 's/POS/O first/JJ/O product/NN/O ,/,/O a/DT/O brain/NN/O protein/NN/O called/VBD/O somatostatin/NN/O ,/,/O proved/VBD/O its/PRP$/O technology/NN/O ././O
The/DT/O next/JJ/O to/TO/O be/VB/O cloned/VBN/O ,/,/O human/JJ/O insulin/NN/O ,/,/O had/VBD/O market/NN/O potential/NN/O and/CC/O Genentech/NNP/B-ORG licensed/VBD/O it/PRP/O to/TO/O Eli/NNP/B-ORG Lilly/NNP/I-ORG ,/,/O which/WDT/O produced/VBD/O 80/CD/O %/NN/O of/IN/O the/DT/O insulin/NN/O used/VBN/O by/IN/O 1.5/CD/O million/CD/O U.S./NNP/B-GPE diabetics/NNS/O ././O
Their/PRP$/O laboratory/NN/O credentials/NNS/O established/VBN/O ,/,/O Boyer/NNP/B-PERSON and/CC/O Swanson/NNP/B-PERSON headed/VBD/O for/IN/O Wall/NNP/O Street/NNP/O in/IN/O 1980/CD/O ././O
The/DT/O trip/NN/O from/IN/O the/DT/O test/NN/O tube/NN/O was/VBD/O not/RB/O without/IN/O snags/NNS/O ././O
Genentech/NN/B-ORG 's/POS/O 1988/CD/O sales/NNS/O were/VBD/O $/$/O 335/CD/O million/CD/O ,/,/O both/CC/O from/IN/O licensing/NN/O and/CC/O its/PRP$/O own/JJ/O products/NNS/O ././O
